Page 43 - 2023-05-中国全科医学

·556· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn February 2023, Vol.26 No.5

作者贡献：石伟娟进行文章的构思与设计、资料整 obstructive pulmonary disease （2017-2020 REPORT）［EB/
理、撰写论文；谢清秀、李玉琪进行资料收集；王凤燕、 OL］. ［2022-03-11］. https://goldcopd.org/goldreports/.
［11］MALEKI-YAZDI M R，KELLY S M，LAM S Y，et al. The burden
杨宇琼、张冬莹、梁振宇进行论文的修订；李时悦、陈
of illness in patients with moderate to severe chronic obstructive
荣昌、郑劲平提供相关资源；王凤燕对论文负责。
pulmonary disease in Canada［J］. Can Respir J，2012，19（5）：
本文无利益冲突。 319-324. DOI：10.1155/2012/328460.
参考文献 ［12］LIANG L R，LI C W，SHEN Y，et al. Long-term trends in
［1］中华医学会呼吸病学分会慢性阻塞性肺疾病学组，中国医师 hospitalization and outcomes in adult patients with exacerbation of
协会呼吸医师分会慢性阻塞性肺疾病工作委员会 . 慢性阻塞性 chronic obstructive pulmonary disease in Beijing，China，from
肺疾病诊治指南（2021 年修订版）［J］. 中华结核和呼吸杂 2008 to 2017［J］. Int J Chron Obstruct Pulmon Dis，2020，15：
志，2021，44（3）：170-205. DOI：10.3760/cma.j.cn112147- 1155-1164. DOI：10.2147/COPD.S238006.
20210109-00031. ［13］WU D，LU J Y，LIU Y H，et al. Positive effects of COVID-19
Chronic Obstructive Pulmonary Disease Group of Chinese Thoracic control measures on influenza prevention［J］. Int J Infect Dis，
Society，Chronic Obstructive Pulmonary Disease Committee 2020，95：345-346. DOI：10.1016/j.ijid.2020.04.009.
of Chinese Association of Chest Physician. Guidelines for the ［14］YOUNG G，PENG X H，REBEZA A，et al. Rapid decline
diagnosis and management of chronic obstructive pulmonary disease of seasonal influenza during the outbreak of COVID-19［J］.
（revised version 2021）［J］. Chinese Journal of Tuberculosis ERJ Open Res，2020，6（3）：00296-2020. DOI：
and Respiratory Diseases，2021，44（3）：170-205. DOI： 10.1183/23120541.00296-2020.
10.3760/cma.j.cn112147-20210109-00031. ［15］LEE H，LEE H，SONG K H，et al. Impact of public health
［2］SOLER-CATALUÑA J J，MARTÍNEZ-GARCÍA M A，SÁNCHEZ interventions on seasonal influenza activity during the COVID-19
P R，et al. Severe acute exacerbations and mortality in patients with outbreak in Korea［J］. Clin Infect Dis，2021，73（1）：e132-
chronic obstructive pulmonary disease［J］. Thorax，2005，60（11）： 140. DOI：10.1093/cid/ciaa672.
925-931. DOI：10.1136/thx.2005.040527. ［16］LIU M，DENG L Z，WANG D Y，et al. Influenza activity during
［3］STOLZ D，PAPAKONSTANTINOU E，GRIZE L，et al. the outbreak of coronavirus disease 2019 in Chinese mainland［J］.
Time-course of upper respiratory tract viral infection and COPD Biosaf Health，2020，2（4）：206-209. DOI：10.1016/j.
exacerbation［J］. Eur Respir J，2019，54（4）：1900407. bsheal.2020.08.005.
DOI：10.1183/13993003.00407-2019. ［17］KUO S C，SHIH S M，CHIEN L H，et al. Collateral benefit of
［4］WANG C C，PRATHER K A，SZNITMAN J，et al. Airborne COVID-19 control measures on influenza activity，Taiwan［J］.
transmission of respiratory viruses［J］. Science，2021，373（6558）： Emerg Infect Dis，2020，26（8）：1928-1930. DOI：
eabd9149. DOI：10.1126/science.abd9149. 10.3201/eid2608.201192.
［5］ESAKANDARI H，NABI-AFJADI M，FAKKARI-AFJADI J，et al. ［18］ZHANG B，ZHOU H W，ZHOU F. Study on SARS-CoV-2
A comprehensive review of COVID-19 characteristics［J］. Biol Proced transmission and the effects of control measures in China［J］.
Online，2020，22：19. DOI：10.1186/s12575-020-00128-2. PLoS One，2020，15（11）：e0242649. DOI：10.1371/journal.
［6］SOO R J J，CHIEW C J，MA S，et al. Decreased influenza pone.0242649.
incidence under COVID-19 control measures，Singapore［J］. ［19］BERGHAUS T M，KARSCHNIA P，HABERL S，et al.
Emerg Infect Dis，2020，26（8）：1933-1935. DOI： Disproportionate decline in admissions for exacerbated COPD during
10.3201/eid2608.201229. the COVID-19 pandemic［J］. Respir Med，2022，191：106120.
［7］LAWLESS M，BURGESS M，BOURKE S. Impact of COVID-19 DOI：10.1016/j.rmed.2020.106120.
on hospital admissions for COPD exacerbation：lessons for future ［20］BRITTON P N，HU N，SARAVANOS G，et al. COVID-19 public
care［J］. Medicina （Kaunas），2022，58（1）：66. DOI： health measures and respiratory syncytial virus［J］. Lancet Child
10.3390/medicina58010066. Adolesc Health，2020，4（11）：e42-43. DOI：10.1016/S2352-
［8］SARC I，LOTRIC DOLINAR A，MORGAN T，et al. Mortality， 4642(20)30307-2.
seasonal variation，and susceptibility to acute exacerbation of ［21］TAN J Y，CONCEICAO E P，WEE L E，et al. COVID-19 public
COPD in the pandemic year：a nationwide population study［J］. health measures：a reduction in hospital admissions for COPD
Ther Adv Respir Dis，2022，16：17534666221081047. DOI： exacerbations［J］. Thorax，2021，76（5）：512-513. DOI：
10.1177/17534666221081047. 10.1136/thoraxjnl-2020-216083.
［9］SAEED M I，SIVAPALAN P，EKLÖF J，et al. Social distancing ［22］CHAN K P F，MA T F，KWOK W C，et al. Significant reduction
in relation to severe exacerbations of chronic obstructive pulmonary in hospital admissions for acute exacerbation of chronic obstructive
disease：a nationwide semi-experimental study during the COVID-19 pulmonary disease in Hong Kong during coronavirus disease 2019
pandemic［J］. Am J Epidemiol，2022，191（5）：874-885. pandemic［J］. Respir Med，2020，171：106085. DOI：
DOI：10.1093/aje/kwab292. 10.1016/j.rmed.2020.106085.
［10］Global initiative for chronic obstructive lung disease. Global （收稿日期：2022-06-11；修回日期：2022-09-22）
strategy for the diagnosis，management，and prevention of chronic （本文编辑：崔莎）